©
John Cairns
The flagship Novo Nordisk – Oxford Fellowship Programme supports research fellows to undertake pioneering early-stage scientific research in diabetes, obesity, cardiovascular, rare blood and other cardiometabolic diseases, with the goal to ultimately bring benefit to patients. The programme supports the development of a new generation of talented international leaders in these fields. Every year, Novo Nordisk funds four Postdoctoral Fellows for a three-year period, hosted at the University of Oxford, providing them with the resources and mentorship needed to advance their research and careers.
The Programme, coordinated by the Radcliffe Department of Medicine since 2013, has funded 44 fellows across 10 University departments. Past fellows have gone on to pursue successful careers closely aligned with the Programme's objectives in academia, industry, and the third sector in the UK and overseas.
Some reflections from past fellows reveal the value of the Programme for kickstarting their careers: 'The ability to work with an industrial partner to devise a project was an amazing opportunity that you rarely get as a young scientist', and 'I valued getting a taste of industrial culture while being completely part of academia'.
Read the full story on the Radcliffe Department of Medicine website.